Low-Conviction Biohaven Buy with Potential Doubling
about 1 month ago
Martin
"I bought a little Biohaven. I bought a new drugtock. I mentioned it in Goodell. I'm not saying it's like high conviction just yet, but if you want to join Godell, you can check out what it is. Little biotech company. I think, you know, it could double."
Martin reveals that he has initiated a small position in Biohaven (assumed ticker BHVN) suggesting a potential doubling in value, although he qualifies the move as low conviction.
Scores
Alpha Potential
8.0/10
Novelty
6.0/10
Credibility
7.0/10
Timeliness
7.0/10
Overall
7.0/10
Sentiment
Bullish
Conviction
Low
Tier
Company Commentary
Related Stocks
Episode Information
Episode:
How I Trade Sarepta, AMD & SMCI Earnings, Hating on Burry, AMGN Stock Review | Martin Shkreli
Source:
The Shkreli Pill
Published:
November 5, 2025
Idea Type:
Company Opinion